EP Patent
EP1572164A2 — Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
Assigned to Pain Therapeutics Inc · Expires 2005-09-14 · 21y expired
What this patent protects
The present invention relates to oral dosage form with active agents in controlled release cores and in immediate release gelatin capsule coats.
USPTO Abstract
The present invention relates to oral dosage form with active agents in controlled release cores and in immediate release gelatin capsule coats.
Drugs covered by this patent
- OxyContin (oxycodone) · Purdue Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.